Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Pulse Biosciences ( (PLSE) ).
Robert W. Duggan, the controlling stockholder and Co-Chairman of Pulse Biosciences, Inc., is considering buying up to 500,000 shares of the company’s common stock by December 2024. This move, approved under the company’s Insider Trading Policy, could potentially influence the market perception and value of Pulse Biosciences’ stock.
See more insights into PLSE stock on TipRanks’ Stock Analysis page.